AI assistant
Sending…
Sanara MedTech Inc. — Director's Dealing 2022
Nov 4, 2022
33339_dirs_2022-11-04_9ebd5ea5-c191-4f1a-8225-64fac8ddc85c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2022-11-02
Reporting Person: Fleming Zachary B. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-02 | Common Stock | S | 20 | $33.02 | Disposed | 37250 | Direct |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.
More from Sanara MedTech Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 17
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Major Shareholding Notification
2026
Apr 14
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 23